Godavari Drugs

Godavari Drugs EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Godavari Drugs (530317.BO) as of Oct 19, 2026 is -3.82. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -11.93 — a change of -68.01% (higher).

EV/FCF

-3.82

YoY

-68.01%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Godavari Drugs is 2026 -3.82 . EV/FCF (Enterprise Value to Free Cash Flow) of Godavari Drugs was 2025 -11.93 . It decreases by -68.01% higher compared to the previous year.

The Godavari Drugs EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
72.35 INR
Jan 1, 2020
-134.47 INR
Jan 1, 2021
-257.55 INR
Jan 1, 2022
13.41 INR
Jan 1, 2023
19.58 INR
Jan 1, 2024
14.91 INR
Jan 1, 2025
-11.93 INR
Jan 1, 2026
-3.82 INR
The Godavari Drugs EV/FCF history
YEAREV/FCFYoY
-3.82-68.01%
-11.93-179.99%
14.91-23.83%
19.58+45.97%
13.41-105.21%
-257.55+91.52%
-134.47-285.87%
72.35-81.88%
399.23+613.44%
55.96-579.94%
-11.66-5.05%
-12.28-99.23%
-1,584.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Godavari Drugs Stock analysis

What does Godavari Drugs do? Godavari Drugs Ltd, based in Secunderabad, Telangana, manufactures active pharmaceutical ingredients (APIs) and intermediates for the global life science industry. The company operates facilities in Nanded, Maharashtra, producing APIs such as Ciprofloxacin HCl and Mefenamic Acid, along with intermediates like A D Lactone and 6 Mercaptopurine. It partners with multinational firms through contract manufacturing and holds active loan licenses for API production. Godavari Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Godavari Drugs stock

EV/FCF (Enterprise Value to Free Cash Flow) of Godavari Drugs is -3.82 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Godavari Drugs changed from -11.93 to -3.82, representing a -68.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Godavari Drugs since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Godavari Drugs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Godavari Drugs

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Godavari Drugs